Breast cancer with intraabdominal metastases. Is surgery necessary?

Andrian Panuța, Iulian Radu, Ionuț Huțanu, Ana-Maria Mușina, Mihaela Buna-Arvinte, Mihaela Mădălina Gavrilescu, Dragoș Viorel Scripcariu, Viorel Scripcariu


Metastatic breast cancer has a very poor prognosis, considering the lack of reliable curative medical or surgical approaches. Patients with stage IV breast cancer usually undergo palliative surgical procedures and symptomatic treatment. In a 5-year period, 1258 patients with breast cancer were treated in our surgical oncology unit. For the current study, we have selected 19 (1.43%) female patients with intraabdominal metastases (peritoneal, hepatic, ovarian etc.) derived from breast cancer, which received at least one surgical procedure in our unit. We compared our data with up-to-date reports and guidelines in order to establish the role and further directions of surgery, and (most importantly) the necessity of surgery itself in the management of this therapeutically disadvantaged patient-group. Even if current guidelines do not recommend surgical treatment of intraabdominal metastases derived from breast cancer, several oncology centers (including our unit) did not discard surgery, especially in patients with solitary metastasis.


metastatic breast cancer, peritoneal metastases, liver metastases, ovarian metastases, unusual origin metastases, cytoreductive surgery, HIPEC

Full Text:



Khanfir A, Lahiani F, Bouzguenda R, Ayedi I, Daoud J, Frikha M. Prognostic factors and survival in metastatic breast cancer: a single institution experience. Rep Pract Oncol Radiother 2013; 18(3):127-132.

Bertozzi S, Londero A, Cedolini C, Uzzau A, Seriau L, Bernardi S, et al. Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer. SpringerPlus 2015; 4(1).

National Comprehensive Cancer Network. NCCN Guidelines Insights: Breast Cancer Version 1.2017.

Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26(suppl 5):v8-v30.

Ruiterkamp J, Ernst M. The role of surgery in metastatic breast cancer. Eur J Cancer 2011; 47:S6-S22.

Bland KI, Klimberg VS, Copeland EM, Gradishar WJ. The breast: comprehensive management of benign and malignant diseases. Philadelphia, PA: Elsevier; 2018.

Barinoff J, Schmidt M, Schneeweiss A, Schoenegg W, Thill M, Keitel S et al. Primary metastatic breast cancer in the era of targeted therapy – Prognostic impact and the role of breast tumour surgery. Eur J Cancer 2017; 83:116-124.

Honoré C, Goéré D, Macovei R, Colace L, Benhaim L, Elias D. Peritoneal carcinomatosis from unusual cancer origins: Is there a role for hyperthermic intraperitoneal chemotherapy? J Visc Surg 2016; 153(2):101-107.

Abbas H, Erridge S, Sodergren M, Papoulas M, Nawaz A, Menon K et al. Breast cancer liver metastases in a UK tertiary centre: Outcomes following referral to tumour board meeting. Int J Surg 2017; 44:152-159.

Mariani P, Servois V, De Rycke Y, Bennett S, Feron J, Almubarak M et al. Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patients. Eur J Surg Oncol 2013; 39(12):1377-1383.

Bacalbasa N, Balescu I, Dima S, Brasoveanu V, Popescu I. Does re-resection of liver metastases for breast cancer hepatic metastases improve survival? HPB 2016; 18:e187.

Garg R, Zahurak M, Trimble E, Armstrong D, Bristow R. Abdominal carcinomatosis in women with a history of breast cancer. Gyn Oncol 2005; 99(1):65-70.

Brinkman D, Misra S, Aydin N. A case report of symptomatic gallbladder disease in the setting of peritoneal carcinomatosis originating from invasive lobular carcinoma of the breast. Int J Surg Case Rep 2016; 24:60-62.

Cardi M, Sammartino P, Mingarelli V, Sibio S, Accarpio F, Biacchi D et al. Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis. World J Surgical Oncol 2015; 13(1):305-311.

Cardi M, Sammartino P, Framarino M, Biacchi D, Cortesi E, Sibio S et al. Treatment of peritoneal carcinomatosis from breast cancer by maximal cytoreduction and HIPEC: A preliminary report on 5 cases. Breast 2013; 22(5):845-849.


Copyright (c) 2019 Andrian Panuța, Iulian Radu, Ionuț Huțanu, Ana-Maria Mușina, Mihaela Buna-Arvinte, Mihaela Mădălina Gavrilescu, Dragoș Viorel Scripcariu, Viorel Scripcariu

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


ISSN: 2360-6975